Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-27T05:03:36.506Z Has data issue: false hasContentIssue false

P62: Agitation in Alzheimer’s Disease (AAD): A Decision Tree for Healthcare Providers

Published online by Cambridge University Press:  02 February 2024

George T. Grossberg
Affiliation:
Professor/Director, Geriatric Psychiatry at Saint Louis University
Samuel W. Fordyce
Affiliation:
Professor/Director, Geriatric Psychiatry at Saint Louis University
Angela Sanford
Affiliation:
Associate Professor of IM-Geriatrics at Saint Louis University
Susan Scanland
Affiliation:
CEO & FounderDementia Connection®
Richard G. Stefanacci
Affiliation:
Jefferson College of Population HealthThomas Jefferson University

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Developed by THE GERONTOLOGIC SOCIETY OF AMERICA

Supported by an unrestricted educational grant from Avanir

  • The prevalence of agitation in Alzheimer’s Disease (AAD) approaches 80%. Patients with AAD have more severe behavioral,depressive, and frontal lobe symptoms and are at increased risk for hospitalization and nursing home placement.

  • Early agitation is a robust predictor of accelerated progression and mortality and is distressing and dangerous for patients and care partners.

  • This presentation was recently developed by the Gerontologic Society of America (GSA) which convened an expert AD Working Group to develop a “Decision Tree” for healthcare providers relative to the assessment of AAD and the employment of Non-Pharmacologic and Pharmacologic treatment options

Type
Posters
Copyright
© International Psychogeriatric Association 2024